M&A Deal Summary |
|
|---|---|
| Date | 2021-11-15 |
| Target | HCML |
| Sector | Healthcare Services |
| Buyer(s) | Apposite Capital |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2006 |
| Size | Small |
| Type | Sector Focused |
Apposite Capital is a private investment firm focused on investing in growth companies in the healthcare sector. The Firm targets UK-based, revenue generating businesses and looks to invest £10 to £25 million over the life of an investment. Specific areas of interest include rehab services, primary and acute care companies, health related software solutions and IT, elderly and specialist healthcare services, medical products, and pharmaceuticals. Apposite Capital was established in 2006 and is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 17 of 19 |
| Sector: Healthcare Services M&A | 8 of 8 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 9 of 10 |
| Country: United Kingdom M&A | 11 of 13 |
| Year: 2021 M&A | 6 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-11-11 |
CrestOptics
Rome, Italy CrestOptics manufactures high-end microscopy instruments under its own brand and as an original equipment manufacturer (OEM). The Company’s instrumentation can be integrated with other high-end imaging systems used in life science research to enhance detection and imaging performance. CrestOptics was formed in 2009 and is based in Rome, Italy. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-01-14 |
Kelso Pharma
Kelso, United Kingdom Kelso Pharma is a business committed to bringing innovative specialty medicines to the European healthcare markets, to provide meaningful benefits to patients and create added value for healthcare stakeholders. Kelso Pharma was founded in 2022 and is based in Kelso, United Kingdom. |
Buy | - |
